The relation between intragastric acidity and duodenal ulcer activity was studied prospectively in 21 patients with endoscopicaily proved duodenal ulcers. The 24 hour intragastric acidity was measured on four separate occasions by continuous recording using combined glass elecetrodes: (a) in the presence of an ulcer crater without treatment; (b) during active ulceration being treated with ranitidine; (c) during early healing after a six week course of ranitidine; (d) during late healing six months after acute ulceration. Intragastric acidity was also monitored in 20 healthy subjects. At all stages of ulcer activity and during all predefined time periods, duodenal ulcer patients had significantly higher gastric acidity than healthy control subjects. Duodenal ulcer patients showed a similar circadian pattern of intragastric acidity during exacerbation of ulcer disease and in remission during the early and late ulcer healing periods. These results argue against a direct relation between the activity of duodenal ulcer disease and gastric acidity. It is concluded that the chronic recurrent course of duodenal ulcer disease does not result from a fluctuation in intragastric acidity.
It has been shown in several studies that duodenal ulcer patients, as a group, secrete more acid than normal subjects.' Nonetheless, the precise role of gastric acid secretion in the pathogenesis of peptic ulcers is poorly defined. Duodenal ulcer disease is characterised by a chronic recurrent course. Whether intragastric acidity fluctuates in relation to the activity of the ulcer disease remains controversial. Some studies have shown little variation in relation to ulcer activity,91 while others show a fall in acid secretion during remission. "-' To elucidate further the relation between gastric acidity and duodenal ulcer activity more investigations are needed.
A new technique for continuous intragastric pH measurement that allows in vivo assessment of gastric acidity has recently been introduced.'4 '5 This method is highly reproducible and is able to detect consistent changes in pH of >0-1 units. The circadian pattern of gastric acidity has not previously been evaluated in the same patient during exacerbation and remission of duodenal ulcer disease. We have, therefore, studied the variations in intragastric acidity over 24 hour periods in duodenal ulcer patients during active and inactive disease. The pH profiles were compared with those of healthy subjects. In addition the response to antisecretory treatment was evaluated.
Methods

PATIENTS AND SUBJECTS
Informed written consent was obtained from each patient and control subject participating in this study, which was approved by the hospital ethics committee. Twenty five duodenal ulcer patients with endoscopically confirmed acute ulceration (ulcer size >5 mm in diameter) were entered into a prospective study of 24 hour gastric acidity. Four patients were lost during follow up, leaving 21 patients for final analysis. A patient number of at least 15 was calculated to allow a detection of consistent pH changes of >0.15 for predefined time periods.'5 The characteristics ofthe patients are shown on Table  I . None of the patients had had previous gastric surgery or had taken any medication during the previous two weeks. All duodenal ulcer patients had at least one ulcer relapse.
Intragastric pH was monitored on four separate occasions: (a) in the presence of an ulcer crater without treatment (within 48 hours of endoscopic confirmation); (b) during active ulceration being treated with 300 mg ranitidine, administered as a single dose at 6 pm for six weeks (five to seven days after beginning of therapy); (c) during early healing (one week after stopping therapy); (d) during late healing (six months after acute ulceration). Upper gastrointestinal endoscopy (Olympus GIF Q 20, Olympus Corp) was performed at the beginning of the study and again six weeks and six months later.
In four patients, ulcer healing was incomplete after a six week course of ranitidine. Three of these patients had large ulcers (> 1 cm) and all were Helicobacter pylori positive. These patients were excluded from the third pH study (early Time (hours) Figure 1 : Median 24 hour pH profiles ofduodenal ulcer patients (acute ulceration) and healthy controls.
healing) and were treated for another six weeks, after which time ulcer healing was endoscopically proved in all but one. Five patients showed an ulcer relapse at endoscopy after six months. All were H pylori positive, but they did not differ in age, sex, or smoking habits from those who remained in remission. Two of the slow healing ulcers relapsed at six months. The five patients with ulcer recurrence were excluded from the final pH study. At six months the drinking and smoking habits in the duodenal ulcer patients had remained unchanged. Intragastric pH was also measured in a group of 20 asymptomatic volunteers (Table I) 18 24 in duodenal ulcer patients with active disease and early and late healing respectively. Figure 2 shows the pH profiles of duodenal ulcer patients during different stages of ulcer disease. Gastric acidity was not significantly different in the presence or absence of an ulcer crater (Table II) . Moreover, gastric pH was essentially the same shortly after healing of a crater and six months later. The integrated AUCs of the 24 hour pH profiles of the duodenal ulcer patients were similar in all stages of ulcer disease, but were significantly lower than those of the healthy controls (Table III) . The individual median 24 hour pH values of all duodenal ulcer patients are shown in Figure 3 . Figure 4 illustrates the response to antisecretory treatment in duodenal ulcer patients. In the presence of ranitidine, an appreciable decline in nocturnal acidity was observed. The profile showed a biphasic curve, with a more accentuated rise in pH after midnight. The antisecretory effect disappeared in the morning hours. Quantitative analysis of the response to treatment is shown in Table II 
